TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.45$ +0.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow VXRT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -54.2% -90.9% +280.0% +742.9% +12.3% -24.6% +55.3% +38.0% +48.6% +2.6% -3.1%
– +23.5% -4.8% -76.2% +13.0% +16.3% +595.1% +103.5% +53.2% +4.0% -18.6% -27.7%
– -89.9% -5.0% -118.8% – – +435.4% +172.4% +50.3% – – –
– -419.4% – -89.7% +162.0% -47.7% +118.8% -175.6% – – – -791.7%
– +0.0% +100.0% -41.5% +504.3% +20.2% +43.9% +321.7% +86.2% -80.5% -70.4% -73.8%
– +92.1% – +144.8% +723.8% -103.2% +43.5% +3,924.3% -58.4% – -148.5% –
– – – – – – – – – – – –
– – -99.9% +166.7% -45.8% +19,438.5% +5,319.8% -97.4% +385.9% -102.1% – –
– +200.0% +33.3% +335.5% +0.0% – – – – – – –
– -100.4% – -99.9% -7,304.2% – +766.6% -9.0% -86.1% -12.7% +271.1% -92.5%
– -348.3% – -236.7% – -79.7% +5,511.1% -85.1% -679.2% – – –
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?